Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis
RCT
OA: closed
CC0
⤵ 81 in-corpus citations
AI-generated summary
This study compared the efficacy and quality of life outcomes between levonorgestrel intrauterine systems and hysterectomy in patients diagnosed with adenomyosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To compare the levonorgestrel intrauterine system (LNG-IUS) with hysterectomy in patients with adenomyosis and to study the effects of both treatments on quality of life (QOL).
DESIGN: Prospective randomized clinical trial.
SETTING: Women's health teaching and research hospital.
PATIENT(S): Eighty-six patients (43 patients for each group) were enrolled, but only 75 women continued the study.
INTERVENTION(S): Women interpreted as having adenomyosis on transvaginal ultrasound and magnetic resonance imaging were assigned to receive either LNG-IUS or hysterectomy.
MAIN OUTCOME MEASURE(S): Clinical measures of menstrual bleeding as number of used pads/day during menstruation, hemoglobin levels, and health-related QOL variables were assessed. Each woman was followed up for 1 year after treatment.
RESULT(S): LNG-IUS increased the hemoglobin levels at the sixth month and first year of the treatment to the comparable levels with hysterectomy. When pretreatment and post-treatment QOL scores of groups were compared, three of the five mean domain scores (physical, environmental, environmental-TR) were increased in patients treated with hysterectomy, while in patients managed with LNG-IUS, all five mean domain scores were increased.
CONCLUSION(S): It seems that LNG-IUS demonstrates significant and comparable improvements in hemoglobin levels to hysterectomy in treating adenomyosis-associated menorrhagia during the first year. Although both treatments lead to improvements in health-related QOL, LNG-IUS seems to have superior effects on psychological and social life. It may be a promising alternative therapy to hysterectomy.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (27)
- Adenomyosis: new knowledge is generating new treatment strategies via openalex
- Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis via openalex
- Diagnosis of Adenomyosis via openalex
- Diagnosis of adenomyosis: a review via openalex
- Diffuse adenomyosis: comparison of endovaginal US and MR imaging with histopathologic correlation via openalex
- Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging via openalex
- Levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding via openalex
- Levonorgestrel-releasing intrauterine system: uses and controversies via openalex
- Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system via openalex
- Prevalence and risk factors of adenomyosis at hysterectomy via openalex
- The effect of levonorgestrel-releasing intrauterine system use on menstrual blood loss and the hemostatic, fibrinolytic/inhibitor systems in women with menorrhagia via openalex
- The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis via openalex
- Transvaginal ultrasound for diagnosis of adenomyosis: a review via openalex
- Transvaginal ultrasound or MRI for diagnosis of adenomyosis via openalex
- Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device via openalex
- Uterine adenomyosis: a need for uniform terminology and consensus classification via openalex
- W2106777940 via openalex
- W2027874761 via openalex
- W2152367884 via openalex
- W2007561870 via openalex
- W2255756224 via openalex
- W1995239566 via openalex
- W6651920706 via openalex
- W6669912067 via openalex
- W1971184127 via openalex
- W6674311667 via openalex
- W2041104023 via openalex
Cited by (50)
- Expert Consensus on the Management of Adenomyosis: A Modified Delphi Method Approach by the Taiwan Endometriosis Society 2025
- Efficacy of levonorgestrel intrauterine system in conservative management of abnormal uterine bleeding: an emerging tool 2025
- Hormonal therapy versus hysterectomy in the management of symptomatic adenomyosis 2025
- Long-term efficacy and safety of levonorgestrel releasing intrauterine system in the treatment of adenomyosis: evidence mapping 2024
- Biological characteristics related to treatment effects of the levonorgestrel-releasing intrauterine system on adenomyosis-associated dysmenorrhoea 2024
- Non-surgical Treatment of Adenomyosis 2024
- Artificial Intelligence in the Management of Women with Endometriosis and Adenomyosis: Can Machines Ever Be Worse than Humans? 2024
- Effectiveness of high-intensity focused ultrasound combined with gonadotropin-releasing hormone agonist or combined with levonorgestrel-releasing intrauterine system for adenomyosis: A systematic review and meta-analysis 2024
- Adenomyosis and Abnormal Uterine Bleeding: Review of the Evidence 2024
- Artificial Intelligence in the Management of Women with Endometriosis and Adenomyosis: Can Machines Ever Be Worse Than Humans? 2024
- Consider fertility-preserving medications when treating adenomyosis 2024
- Adenomyosis 2024
- Evaluation of Endpoints Used in Clinical Trials on Adenomyosis - A Systematic Review 2023
- [Directive clinique no 437 : Diagnostic et prise en charge de l'adénomyose] 2023
- Gynecological prerequisites for the development of chronic pelvic pain syndrome – diagnosis and treatment (Literature review) 2023
- The Present and the Future of Medical Therapies for Adenomyosis: A Narrative Review 2023
- Clinical Efficacy of Levonorgestrel Releasing Intrauterine System versus Dienogest for Women having Symptomatic Adenomyosis 2023
- Patient satisfaction, sexual function and decision regret in use of levonorgestrel intrauterine device 2023
- Guideline No. 437: Diagnosis and Management of Adenomyosis 2023
- Endovascular Embolization of Uterine Myomas and Adenomyosis 2023
- The Asian Society of Endometriosis and Adenomyosis guidelines for managing adenomyosis 2023
- Nonsurgical management of adenomyosis: an overview of current evidence 2022
- Higher Risk of Anxiety and Depression in Women with Adenomyosis as Compared with Those with Uterine Leiomyoma 2022
- Adenomyosis in Reproductive Years: Abnormal Uterine Bleeding and Pain 2022
- Current diagnosis and management of adenomyosis in Canada: A survey of Canadian gynaecologists 2022
- Long-term Efficacy and Safety of Levonorgestrel - releasing Intrauterine System in the Treatment of Adenomyosis: Evidence Mapping and Meta-analysis 2022
- Uterine Artery Embolization for Symptomatic Adenomyosis: Proceedings from a Society of Interventional Radiology Foundation Research Consensus Panel 2022
- Variation of outcome reporting in studies of interventions for heavy menstrual bleeding: a systematic review 2022
- Conservative surgical and drug therapies for adenomyosis Medicine 2022
- [Management of women with abnormal uterine bleeding: Clinical practice guidelines of the French National College of Gynecologists and Obstetricians (CNGOF)] 2022
- Adenomyosis - An Overview 2022
- Medical Treatment of Adenomyosis 2022
- Effects of Etonogestrel implants on pelvic pain and menstrual flow in women suffering from adenomyosis or endometriosis: Results from a prospective, observational study 2021
- A systematic review of outcome reporting and outcome measures in studies investigating uterine-sparing treatment for adenomyosis 2021
- Endometriosis increases the rate of spontaneous early miscarriage in women who have adenomyosis lesions 2021
- Current and Prospective Treatment of Adenomyosis 2021
- Treatment of Uterine Pathology 2020
- Role of Hormones in Common Benign Uterine Lesions: Endometrial Polyps, Leiomyomas, and Adenomyosis 2020
- Adenomiosis. Una gran desconocida: ¿Qué debemos saber? 2020
- Current and Future Medical Therapies for Adenomyosis 2020
- Histopathology diagnosis in women who underwent a hysterectomy for a benign condition. 2020
- Benign Uterine Diseases 2019
- Gynecological associated disorders and management 2019
- [Efficacy and adverse effects of levonorgestrel-releasing intrauterine system in treatment of adenomyosis] 2019
- Transvaginal ultrasound-guided biopsy of adenomyosis 2019
- Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system 2019
- Is High-intensity Focused Ultrasound Effective for the Treatment of Adenomyosis? A Systematic Review and Meta-analysis 2019
- High-intensity focused ultrasound (HIFU) combined with gonadotropin-releasing hormone analogs (GnRHa) and levonorgestrel-releasing intrauterine system (LNG-IUS) for adenomyosis: a case series with long-term follow up 2019
- Pharmacological Treatment for Symptomatic Adenomyosis: A Systematic Review 2019
- Clinical Efficacy and Safety of Major Uterine Wall Resection and Reconstruction of the Uterus Combined with LNG-IUS for the Treatment of Severe Adenomyosis 2019
Source provenance
- europepmc
- last seen: 2026-10-12T06:17:10.165071+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:08:15.389298+00:00
- unpaywall
- last seen: 2026-09-22T06:12:16.469521+00:00
License: CC0
· commercial use OK